SCHEMBL23974737

SCHEMBL23974737

CC(C)(C)NC(Cc1ccc(CN)cc1)C(=O)C(C)(C)C

nearest known ligand 0.40

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ LOXL2 Q9Y4K0 1/20 0.40
▸ F9 P00740 1/20 0.40
▸ TPSAB1 Q15661 3/20 0.38
▸ HDAC3 O15379 1/20 0.38
▸ HDAC6 Q9UBN7 1/20 0.38
▸ NCOR2 Q9Y618 1/20 0.38
▸ PLG P00747 4/20 0.37
▸ KLK1 P06870 4/20 0.37
▸ KLK6 Q92876 4/20 0.37
▸ KLKB1 P03952 2/20 0.37
▸ GRIA1 P42261 1/20 0.37
▸ MME P08473 1/20 0.37
▸ ACE P12821 1/20 0.37
▸ ACE2 Q9BYF1 1/20 0.37
▸ BACE1 P56817 1/20 0.36
▸ BACE2 Q9Y5Z0 1/20 0.36
▸ F2 P00734 1/20 0.36
▸ MAPT P10636 1/20 0.35
▸ CYP24A1 Q07973 1/20 0.35
▸ KDM4E B2RXH2 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL18995791 1.00 LOXL2 (0.40) LOXL2F9TPSAB1HDAC3HDAC6
SCHEMBL685444 0.88 CA2 (0.39) GRIA1MMEACEACE2MAPT
SCHEMBL25454926 0.88 CA2 (0.39) GRIA1MMEACEACE2MAPT
SCHEMBL20243835 0.87 LOXL2 (0.37) LOXL2F9TPSAB1HDAC3HDAC6
SCHEMBL12250719 0.86 ESR1 (0.46) GRIA1MMEACEACE2MAPT
SCHEMBL12250692 0.86 ATM (0.43) MMEACEACE2MAPTCYP24A1
SCHEMBL13630710 0.86 ESR1 (0.46) GRIA1MMEACEACE2MAPT
SCHEMBL10061085 0.86 ATM (0.43) MMEACEACE2MAPTCYP24A1
SCHEMBL26417010 0.86 ATM (0.43) MMEACEACE2MAPTCYP24A1
SCHEMBL12250708 0.86 ESR1 (0.46) GRIA1MMEACEACE2MAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11827684-B2 Human interleukin-2 conjugates biased for the interleukin-2 receptor beta GAMMAc dimer and conjugated to a nonpeptidic, water-soluble polymer MERCK SHARP & DOHME LLC (US) 2023-11-28 — — US disclosed
US-20210340207-A1 HUMAN INTERLEUKIN-2 CONJUGATES BIASED FOR THE INTERLEUKIN-2 RECEPTOR BETA GAMMAc DIMER AND CONJUGATED TO A NONPEPTIDIC, WATER-SOLUBLE POLYMER MERCK SHARP & DOHME CORP. (US) 2021-11-04 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20210340207-A1 HUMAN INTERLEUKIN-2 CONJUGATES BIASED FOR THE INTERLEUKIN-2 RECEPTOR BETA GAMMAc DIMER AND CONJUGATED TO A NONPEPTIDIC, WATER-SOLUBLE POLYMER IL2, IL2RA, IL6ST LOXL2 1873/4885F9 2178/4885TPSAB1 2507/4885
US-11827684-B2 Human interleukin-2 conjugates biased for the interleukin-2 receptor beta GAMMAc dimer and conjugated to a nonpeptidic, water-soluble polymer IL2, IL2RA, IL6ST LOXL2 1873/4885F9 2178/4885TPSAB1 2507/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback